Dr. Alan K Davis - Psychedelics, Depression, and Healing the Mind

ManTalks Podcast

Connor Beaton

Education, Self-improvement, Health & Fitness, Relationships, Society & Culture, Mental Health

4.8 • 591 Ratings

🗓️ 16 November 2020

⏱️ 54 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

I’m excited for this one! On November 4th, JAMA Psychiatry published a study with an impressive claim: psilocybin was (get this) at least 4 times more effective on major depression than the usual antidepressants. Plant medicine is a big fascination for me, so it was so rewarding to speak with one of the authors that study, Dr. Alan K Davis. Alan is on the bleeding edge of both the research and the practical treatment at Johns Hopkins, and we talk about how the study was set up, the barriers involved, the effects on the patients, and some of the upcoming (and promising) studies in the pipeline. Dr. Alan K Davis is an Assistant Professor of Social Work at The Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Dr. Davis’s clinical experience includes working with people diagnosed with trauma-based psychological problems such as addiction, PTSD, depression, and anxiety. His clinical expertise includes providing evidenced-based treatments such as motivational interviewing, cognitive behavioral therapy, acceptance and commitment therapy, and psilocybin-assisted psychotherapy. Consistent with his clinical interests, his research interests and expertise focus on contributing to the knowledge of and ability to help those suffering with substance use and mental health problems, understanding how to improve clinical outcomes through examining new treatments, and developing ways to conceptualize substance use and mental health problems through a strengths-based approach. He recently completed a clinical trial of psilocybin therapy for major depressive disorder and current trials include exploring this treatment for patients with co-occurring alcohol use disorder and depression and patients with anorexia. He actively explores topics related to naturalistic psychedelic use among several populations including people of color who have experienced racial trauma, Spanish-speaking people, and people who use novel psychedelics such as 5-MeO-DMT. Connect with Alan: -Ohio State University -Johns Hopkins Center for Psychedelic and Consciousness Research -Source Research Foundation (grants and support for students) Are you looking to find your purpose, navigate transition, or fix your relationships, all with a powerful group of men from around the world? Check out The Alliance and join me today. Check out our Facebook Page or the Men's community. Subscribe on Apple Podcasts | Google Podcasts | Spotify For more episodes visit us at ManTalks.com | Facebook | Instagram | Twitter Did you enjoy the podcast? If so, please leave us a review on Apple Podcasts or Stitcher. It helps our podcast get into the ears of new listeners, which expands the ManTalks Community Editing & Mixing by: Aaron The Tech See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to The Man Talk Show. I'm Connor Beaton.
0:13.6	And joining me today is Dr. Alan Davis, who is the assistant professor of social work at the Ohio State University and an adjunct assistant professor
0:22.0	in the psychedelic research unit at Johns Hopkins University, which is where we're talking about
0:26.9	today. So Dr. Davis's clinical experience includes working with people diagnosed with trauma-based
0:32.3	psychological problems such as addiction, PTSD, depression, and anxiety. His clinical expertise includes providing evidence-based treatments such as addiction, PTSD, depression, and anxiety. His clinical expertise includes providing
0:39.4	evidence-based treatments such as motivational interviewing, cognitive behavioral therapy,
0:44.8	acceptance and commitment therapy, and specifically psilocybin-assisted psychotherapy. So consistent
0:51.5	with his clinical interests, his research interests and expertise, because he's both a
0:57.4	clinician and a researcher, his research focuses on contributing to the knowledge of an ability
1:03.8	to help those suffering with substance use and mental health problems.
1:07.9	So his psychedelic research focuses on clinical trials with psilocybin specifically,
1:13.0	or magic mushrooms, for people with depression and exploring psychological mechanisms by which
1:19.6	psilocybin improves mental health and functioning. So that's what we're going to talk about
1:24.3	here today. So you may have seen recently there was a big
1:28.3	study released from Johns Hopkins University. The research has been largely publicized because it was
1:35.2	really focusing in on the use of psychedelics, specifically psilocybin on depression. So Dr. Alan
1:42.8	Davis was a major component of that research and that clinical trial,
1:47.8	those clinical studies. And so he and I are going to dive deep into the findings of that research.
1:54.1	We are going to talk about how they actually set up clinical studies for this, some of the
1:58.5	blocks around being able to take psychedelic research
2:02.6	to the next step, the next level. We're going to talk about how they set up those clinical trials,
2:07.3	what happens in the body, what some people actually experience when they go through
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Connor Beaton, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Connor Beaton and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.